Category: Psychedelic Bulletin - Page 14 - Psychedelic Alpha

Read more about the article Psychedelic Bulletin: MindMed Announces R(-)-MDMA Program; Psilocybin for Anxiety Study Secures Ethics Approval; UCL Joins the Renaissance

Psychedelic Bulletin: MindMed Announces R(-)-MDMA Program; Psilocybin for Anxiety Study Secures Ethics Approval; UCL Joins the Renaissance

Post published:October 29, 2021
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: Small Pharma Secures Fast-Track Designation in UK; Boris Johnson to Consider Rescheduling Psilocybin; COMPASS Reports Psilocybin Group Therapy Data

Psychedelic Bulletin: Small Pharma Secures Fast-Track Designation in UK; Boris Johnson to Consider Rescheduling Psilocybin; COMPASS Reports Psilocybin Group Therapy Data

Post published:October 22, 2021
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: atai Launches Precision Psychiatry Company; DEA Proposes Further Increase to Psychedelics Production Quotas

Psychedelic Bulletin: atai Launches Precision Psychiatry Company; DEA Proposes Further Increase to Psychedelics Production Quotas

Post published:October 16, 2021
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: Delix Raises $70m Series A; Toronto Gets Psychedelics Research Centre; Elon Musk Endorses Psychedelics

Psychedelic Bulletin: Delix Raises $70m Series A; Toronto Gets Psychedelics Research Centre; Elon Musk Endorses Psychedelics

Post published:October 1, 2021
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: Are REMS Patents the Next Frontier in the Psychedelics Patent Skirmish? Johns Hopkins Researcher Scores U.S. Government Grant

Psychedelic Bulletin: Are REMS Patents the Next Frontier in the Psychedelics Patent Skirmish? Johns Hopkins Researcher Scores U.S. Government Grant

Post published:September 24, 2021
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: COMPASS Pathways Acquires IP Portfolio; Wesana to Explore MDMA for TBI With MAPS; Nine Perfect Strangers Draws Attention to Psychedelics

Psychedelic Bulletin: COMPASS Pathways Acquires IP Portfolio; Wesana to Explore MDMA for TBI With MAPS; Nine Perfect Strangers Draws Attention to Psychedelics

Post published:September 17, 2021
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: Proliferation of Psilocybin-Related Drug Development; Biden-Harris Administration Aims to Reduce Barriers to Schedule I Research

Psychedelic Bulletin: Proliferation of Psilocybin-Related Drug Development; Biden-Harris Administration Aims to Reduce Barriers to Schedule I Research

Post published:September 10, 2021
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: DEA Proposes Increase to Psilocybin Quota; Field Trip Launches KAP Co-Operative Program; MindMed Files DTx Patent Application

Psychedelic Bulletin: DEA Proposes Increase to Psilocybin Quota; Field Trip Launches KAP Co-Operative Program; MindMed Files DTx Patent Application

Post published:September 3, 2021
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: California Decrim. Bill Put on Pause; MindMed Inks Real-World Evidence Collaboration

Psychedelic Bulletin: California Decrim. Bill Put on Pause; MindMed Inks Real-World Evidence Collaboration

Post published:August 27, 2021
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Bulletin: Beckley Psytech Raises $80m in Series B; Bright Minds Biosciences Reports Positive Preclinical Findings; Psychedelics DNA Test Called Into Question

Psychedelic Bulletin: Beckley Psytech Raises $80m in Series B; Bright Minds Biosciences Reports Positive Preclinical Findings; Psychedelics DNA Test Called Into Question

Post published:August 20, 2021
Post category:Psychedelic Bulletin

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.